TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #14968 · Jul 16

#java#database#hbase#java The Apache License 2.0 is a free and permissive open-source license that lets you use, modify, and share software for any purpose, including commercial use. You can distribute original or changed versions without paying royalties, but you must include the original copyright notice, the license text, and disclose any major changes you make. This license also grants patent rights and protects contributors from liability. Its flexibility allows you to use open-source code in your own projects, even proprietary ones, while ensuring proper credit and legal clarity. This benefits you by giving freedom to innovate and share software safely and legally[1][2][3][4]. https://github.com/apache/hbase

Results

3 similar posts found

Search: #genetherapy

当前筛选 #genetherapy清除筛选
Venture Village Wall 🦄

@venturevillagewall · Post #3846 · 01/11/2025, 10:00 AM

Funding Rounds Boost Healthcare & Energy Sectors Several companies have recently secured significant funding: - Arizona Public Service: $1.81B, Jan 8, 2025. - Nephron Pharmaceuticals: $350M, Jan 10, 2025. - Windward Bio: $200M, Jan 10, 2025. - Timberlyne Therapeutics: $180M, Jan 10, 2025. - Hippocratic AI: $141M, Jan 9, 2025. - Ouro Medicines: $120M, Jan 10, 2025. - Movement Labs: $100M, Jan 8, 2025. - Rhygaze: $86M, Jan 10, 2025. - Light Horse Therapeutics: $62M, Jan 9, 2025. - Overhaul: $55M, Jan 10, 2025. - Numab: $54.94M, Jan 9, 2025. - Harsoria Healthcare: $20M, Jan 9, 2025. - Huazhi Energy: $13.64M, Jan 8, 2025. - Lava Network: $12M, Jan 9, 2025. - Pakistan Refinery Ltd: $11.24M, Jan 8, 2025. Find detailed updates on respective company websites for more insights. #Funding#Healthcare#Biotech#Energy#Pharmaceuticals#AI#Tech#GeneTherapy#Blockchain#VentureCapital#Investment

Venture Village Wall 🦄

@venturevillagewall · Post #3412 · 12/18/2024, 12:11 PM

$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform